163 related articles for article (PubMed ID: 33466686)
1. Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association.
Federizon J; Feugmo CGT; Huang WC; He X; Miura K; Razi A; Ortega J; Karttunen M; Lovell JF
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466686
[TBL] [Abstract][Full Text] [Related]
2. Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose.
Huang WC; Deng B; Mabrouk MT; Seffouh A; Ortega J; Long C; Miura K; Wu Y; Lovell JF
Malar J; 2020 Aug; 19(1):309. PubMed ID: 32859199
[TBL] [Abstract][Full Text] [Related]
3. Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.
Mabrouk MT; Huang WC; Deng B; Li-Purcell N; Seffouh A; Ortega J; Ekin Atilla-Gokcumen G; Long CA; Miura K; Lovell JF
Int J Pharm; 2020 Nov; 589():119843. PubMed ID: 32890653
[TBL] [Abstract][Full Text] [Related]
4. Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment.
Huang WC; Deng B; Seffouh A; Ortega J; Long CA; Suresh RV; He X; Miura K; Lee SM; Wu Y; Lovell JF
NPJ Vaccines; 2020; 5(1):23. PubMed ID: 32218995
[TBL] [Abstract][Full Text] [Related]
5. An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice.
Shao S; Huang WC; Lin C; Hicar MD; LaBranche CC; Montefiori DC; Lovell JF
Ann Biomed Eng; 2020 Jul; 48(7):1991-2001. PubMed ID: 31832930
[TBL] [Abstract][Full Text] [Related]
6. A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.
Huang WC; Deng B; Lin C; Carter KA; Geng J; Razi A; He X; Chitgupi U; Federizon J; Sun B; Long CA; Ortega J; Dutta S; King CR; Miura K; Lee SM; Lovell JF
Nat Nanotechnol; 2018 Dec; 13(12):1174-1181. PubMed ID: 30297818
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.
Federizon J; Frye A; Huang WC; Hart TM; He X; Beltran C; Marcinkiewicz AL; Mainprize IL; Wills MKB; Lin YP; Lovell JF
Vaccine; 2020 Jan; 38(4):942-950. PubMed ID: 31727504
[TBL] [Abstract][Full Text] [Related]
8. Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens.
Shao S; Geng J; Ah Yi H; Gogia S; Neelamegham S; Jacobs A; Lovell JF
Nat Chem; 2015 May; 7(5):438-46. PubMed ID: 25901823
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of Ni-NTA-bearing microspheres.
Lauer SA; Nolan JP
Cytometry; 2002 Jul; 48(3):136-45. PubMed ID: 12116359
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.
Tiwari S; Goyal AK; Mishra N; Khatri K; Vaidya B; Mehta A; Wu Y; Vyas SP
J Control Release; 2009 Dec; 140(2):157-65. PubMed ID: 19686788
[TBL] [Abstract][Full Text] [Related]
11. Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.
Bale S; Goebrecht G; Stano A; Wilson R; Ota T; Tran K; Ingale J; Zwick MB; Wyatt RT
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592540
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.
Watson DS; Platt VM; Cao L; Venditto VJ; Szoka FC
Clin Vaccine Immunol; 2011 Feb; 18(2):289-97. PubMed ID: 21159923
[TBL] [Abstract][Full Text] [Related]
13. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
Mlambo G; Maciel J; Kumar N
Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
[TBL] [Abstract][Full Text] [Related]
14. Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.
Scally SW; McLeod B; Bosch A; Miura K; Liang Q; Carroll S; Reponen S; Nguyen N; Giladi E; Rämisch S; Yusibov V; Bradley A; Lemiale F; Schief WR; Emerling D; Kellam P; King CR; Julien JP
Nat Commun; 2017 Nov; 8(1):1568. PubMed ID: 29146922
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
Chichester JA; Green BJ; Jones RM; Shoji Y; Miura K; Long CA; Lee CK; Ockenhouse CF; Morin MJ; Streatfield SJ; Yusibov V
Vaccine; 2018 Sep; 36(39):5865-5871. PubMed ID: 30126674
[TBL] [Abstract][Full Text] [Related]
16. Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.
Platt V; Huang Z; Cao L; Tiffany M; Riviere K; Szoka FC
Bioconjug Chem; 2010 May; 21(5):892-902. PubMed ID: 20384362
[TBL] [Abstract][Full Text] [Related]
17. The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.
van Broekhoven CL; Altin JG
Biochim Biophys Acta; 2005 Oct; 1716(2):104-16. PubMed ID: 16225839
[TBL] [Abstract][Full Text] [Related]
18. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
Li Y; Leneghan DB; Miura K; Nikolaeva D; Brian IJ; Dicks MD; Fyfe AJ; Zakutansky SE; de Cassan S; Long CA; Draper SJ; Hill AV; Hill F; Biswas S
Sci Rep; 2016 Jan; 6():18848. PubMed ID: 26743316
[TBL] [Abstract][Full Text] [Related]
19. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
Sookpongthai P; Utayopas K; Sitthiyotha T; Pengsakul T; Kaewthamasorn M; Wangkanont K; Harnyuttanakorn P; Chunsrivirot S; Pattaradilokrat S
Parasit Vectors; 2021 Nov; 14(1):571. PubMed ID: 34749796
[TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
de Graaf H; Payne RO; Taylor I; Miura K; Long CA; Elias SC; Zaric M; Minassian AM; Silk SE; Li L; Poulton ID; Baker M; Draper SJ; Gbesemete D; Brendish NJ; Martins F; Marini A; Mekhaiel D; Edwards NJ; Roberts R; Vekemans J; Moyle S; Faust SN; Berrie E; Lawrie AM; Hill F; Hill AVS; Biswas S
Front Immunol; 2021; 12():694759. PubMed ID: 34335606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
